Tuesday, April 29, 2025

Philippines first country to grant permit for use of Sepsivac for...

Ahmedabad, September 21, 2021: The Philippines has become the first country to grant the emergency permit for use of Sepsivac, developed by Ahmedabad-based Cadila...

Biotechnology

Conjunctivitis at its peak by NIIMS

New Delhi, August 17, 2023: Conjunctivitis or pink eyes or red eyes is spreading at a fast rate. It is highly infectious and might...

Pioneering Real World Study Reveals Successful Tele-ICU Collaboration for Remote Critical Care

BENGALURU, AUGUST 24,2023: In a recent publication that promises to reshape the landscape of healthcare accessibility, a research paper titled "A successful model of a Private-Public...

IT & Software Support

Wipro GE Healthcare keen to make diagnostics affordable to all

Wipro GE Healthcare is keen to invest in technologies that are affordable to all.

Terri Bresenhem, President and Chief Executive, GE Healthcare, told reporters here on Wednesday that the company has not only been expanding its presence in India for over two decades now, but investing at least 30 per cent more in recent years. “The investment is both in terms of manpower and strengthening our research and development facility,” she said.

INDIA MANUFACTURE

“We are striving to make healthcare affordable to all. While most medical equipment companies that have established their presence here import close to 80 per cent of their equipment, our import component is less. At GE Healthcare, we design and manufacture 30 per cent of the equipment in India. We have a strong research team, high quality thinkers and innovators here,” she added.

Appointments

Swiss based Pharma Veteran, Balasubramanian Srinivasan (Srini Srinivasan) joins TAKE Solutions Board as an...

Chennai, December 07, 2019: TAKE Solutions Ltd. , a globally recognized domain intensive services provider in Life Sciences, today announced the appointment of Srini Srinivasan...

Awards

Global Recognition For Aanjaneya Lifecare, Enters The Elite List of Golden Peacock Awards, Receives...

Aanjaneya Lifecare Selected in Pharmaceutical Sector For Robust Growth, Corporate Governance & Innovative Business Approach in tough Market Conditions.

Mumbai, Maharashtra, India, Saturday, February 09, 2013 -- (Business Wire India) -- Mumbai-based Aanjaneya Lifecare Limited BSE code (533412), the vertically integrated pharmaceutical company with manufacturing and marketing capabilities in APIs (Active Pharmaceutical Ingredients) with focus on anti-malarial, and finished dosage forms (FDFs) catering to various therapeutic segments, has received yet another feather in its cap at Golden Peacock National Quality Award - 2012 by winning the coveted title in Bangalore on 8th Feb 2013 in the presence of distinguished gathering of business leaders, jurists, academics, environmentalists, economists, legislators and policy makers during the 23rd World Congress on Leadership and Quality of Governance.

Financial Results

Clinical Trails

BigBrother Nutra Care unveils clinical trial report for India’s first protective shield against Oral...

  Mumbai, July 05, 2019: BigBrother Nutra Care unveiled the clinical trial report for it’s novel first of it's kind natural Nutraceutical product with active...

Media Partner

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Importance of eye health during this lockdown and 5 ways to keep our eyes...

By Hemanth Manay, CEO & Chief Consultant Optometrist, S.R. Gopal Rao Opticians & Optometrists The current situation does not allow for us to move out...

Tips to take care of Eyes post the cataract

By Dr P K Santhakumari, Founder, Matha Ayurveda Eye Hospital Cataract surgery is a very common procedure nowadays. It is the removal of the opaque...

Product News

LANXESS commissions two additional production lines for composite material Tepex

Bond-Laminates subsidiary expands capacity at Brilon site by 50 percent Many opportunities in the automotive and consumer electronics industries  Cologne, September 20, 2019: At...

Approvals

Lupin Receives Tentative Approval for Empagliflozin and Linagliptin Tablets

Mumbai, July 23 2020: Pharma major Lupin Limited (Lupin) announced that it has received tentative approval for its Empagliflozin and Linagliptin Tablets, 10 mg/5...

Kerala Ayurveda Limited receives US patent for its herbal formulation

 The United States Patent and Trademark Office (USPTO) has granted KAL its first patent for a proprietary herbal formulation that is uniquely processed...

Spotlight

Investments

Packaging

Latest News

Dental Care

Tips to maintain oral health!

By Dr.MS Prasad, Dental Surgeon, Columbia Asia Referral Hospital Yeshwanthpur It has been said that a person’s real happiness begins from the plate and is...

Hospital Management

Drug Discovery & Development

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and...

New Delhi, July 22, 2020: Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and...

Suppliers

Technology

Companies

3rdAnnual Pharma GMP and Quality Management 2023

Virtual Day 0- March 10th In-person Day 1&2- Mar 16th-17th  About the Event: Following the highly successful 2nd Edition, Eminence Business Media is planning the 3rd Annual...

Syngene reports solid Q4 growth and ends the year on a...

Q4 revenue up 13% to Rs. 628 Cr, PAT up 20% to Rs 120 Cr; full year revenue up 10% to Rs 2094...

Marketing

Our Partners

[lsp_slider slider=our_partners]

Machinery & Equipments